Sunday, May 18, 2014

Update – The IBD Top 50 Stocks Strategy

Here’s a late update on the IBD Top 50 stocks investing strategies vs. $SPY

image Growth returned to the IBD 50 this past week.  All of the IBD weekly strategies ending 5/16/2014 outperformed the SP500.  For the week, there were 32 stocks up and 18 stocks downfor the IBD 50. 

CAR led the IBD 50 with a return of 6.3% for the week.  The biggest loser for the IBD 50 was HOLI, down 5.75%.

The total return since 2/8/2014 is underperforming the SP500.  None of the IBD models has a positive return for 2014.  The more diversified model (with 50 stocks) is performing better than the less-diversified models.  The market index is near an all time high, but the small caps and Nasdaq are lagging. 

The portfolio is sold at the closing price Friday night, and rebalanced into the make-up of the IBD top 50.  Dividends are excluded from total returns.

Trading costs $268.75.

image The IBD monthly strategy is mixed for the month of May.  The IBD 5 and 10 models are positive  The more diversified models are negative.

The total returns for the monthly models continue to trail the SP500.  While it may seem as if all hope is lost, the models consist of growth stocks.  If growth stocks ever see cash inflow again, these stocks could once again take the lead.

GMCR leads the monthly IBD 50 models with a 22% return.  On the downside, MTW has fallen 12.6%.

For the month of May, the IBD 50 has 19 gainers and 31 losers. 

Trading costs $29.85.

As I have been reading reviews of investing and rebalancing into model portfolios, the trading costs of rebalancing weekly or monthly is often discussed.  Going forward, I will list the “in and out” rebalancing costs for each strategy.  I will assume a $9.95 cost to sell last week’s or last month’s portfolio, and $9.95 to buy the new weekly or monthly portfolio.  (Imagine the costs of doing this with individual stocks, compared to using Motif.  Note that Motif limits the size of portfolios to 30 stocks).

The Top 25 holdings are listed at at Motif Investing.  (A check as of 3/31/2014 shows that the ability to view all holdings is limited to Motif members and IBD subscribers).

None of the above strategies are a recommendation to buy or sell stocks.  These are model portfolios constructed for entertainment only.

This is the IBD portfolio performance since 2/8/2014.  Each portfolio begins with $10,000 and then invests an equal amount in the top 5, 10, 25 and 50 IBD stocks at the closing prices on Friday for the weekly model, and at the closing prices on the last trading day of the month for the monthly model.  Since IBD changes the make up of their top stocks daily, this will only rebalance on Fridays or end of month.  It is assumed that trading costs are $9.95 to “buy” a model portfolio, and $9.95 to “sell” a model portfolio.  Thus, each weekly or monthly rebalance out of the previous portfolio and into the new portfolio costs $19.90.  Daily changes in the IBD 50 or stock rankings are not considered.  Changes in IBD’s overall market views are not considered.  Stop loss orders or other market timing strategies are not considered. 

Based on a blog entry from Paladin Money.  See Investors Business Daily for more information on the IBD 50.  See Motif Investing for their IBD Top 25 portfolio, and the ability to construct your own portfolio of stocks.

blog comments powered by Disqus